| Subject: | FDA Announces Nationwide Recall of Duragesic 25 mcg/hr (fentanyl transdermal system) CII Pain Patches |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 15 Feb 2008 - 06:00 pm |
| Audience: Pain management specialists, other healthcare professionals, patientsThe FDA, PriCara and Sandoz Inc. have announced a nationwide recall of all lots of 25 mcg/hr Duragesic Patches sold in the United States. The product is being recalled because the patches may have a cut along one side of the drug reservoir within the patch, which may result in the possible release of fentanyl gel that can expose patients or caregivers directly to fentanyl gel on the skin. Fentanyl exposure may lead... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
